Article ID Journal Published Year Pages File Type
5841757 Life Sciences 2015 7 Pages PDF
Abstract
These results suggest that the 11β-HSD1 inhibitor, UI-1499, may serve as a novel drug candidate for the treatment of type 2 diabetes and metabolic syndrome.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499
Authors
, , , , ,